Wikidata

(Q40508930)

English

Phase II study of low-dose decitabine in patients with chronic myelogenous leukemia resistant to imatinib mesylate

scientific article published on 9 May 2005

In more languages

Statements

title
Phase II study of low-dose decitabine in patients with chronic myelogenous leukemia resistant to imatinib mesylate (English)
1 reference
stated in
Europe PubMed Central
PubMed ID
15883410
retrieved
21 September 2017
publication date
9 May 2005
1 reference
stated in
Europe PubMed Central
PubMed ID
15883410
retrieved
21 September 2017
page(s)
3948-3956
1 reference
stated in
Europe PubMed Central
PubMed ID
15883410
retrieved
21 September 2017

Identifiers

 
edit
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit
                    Retrieved from "https://www.wikidata.org/w/index.php?title=Q40508930&oldid=1899476275"